Related references
Note: Only part of the references are listed.Evaluation of a Radiolabeled Macrocyclic Peptide as Potential PET Imaging Probe for PD-L1
Nedra Jouini et al.
CHEMMEDCHEM (2022)
64Cu-labeling of small extracellular vesicle surfaces via a cross-bridged macrocyclic chelator for pharmacokinetic study by positron emission tomography imaging
Shota Warashina et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Cu-64-labeling of small extracellular vesicle surfaces via a cross-bridged macrocyclic chelator for pharmacokinetic study by positron emission tomography imaging
Shota Warashina et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Review: PET imaging with macro- and middle-sized molecular probes
Hidefumi Mukai et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Liquid biopsy enters the clinic - implementation issues and future challenges
Michail Ignatiadis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
KRAS Inhibitor Resistance in MET-Amplified KRASG12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms
Shinichiro Suzuki et al.
CLINICAL CANCER RESEARCH (2021)
HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence
Jianjiang Fu et al.
ONCOGENE (2021)
Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges
Toshio Fujino et al.
LUNG CANCER-TARGETS AND THERAPY (2021)
Organic Cation Transporters in Health and Disease
Hermann Koepsell
PHARMACOLOGICAL REVIEWS (2020)
Diagnostic value of PET/CT with 11C-methionine (MET) and 18F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
Tomoya Ogawa et al.
EJNMMI RESEARCH (2020)
Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer
Juergen Wolf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cyclic Peptide-Based Biologics Regulating HGF-MET
Hiroki Sato et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Macrocyclic peptide-based inhibition and imaging of hepatocyte growth factor
Katsuya Sakai et al.
NATURE CHEMICAL BIOLOGY (2019)
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance
Kenji Kita et al.
CANCER SCIENCE (2019)
Peptide-based PET quantifies target engagement of PD-L1 therapeutics
Dhiraj Kumar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Pharmacokinetic evaluation of liposomal nanoparticle-encapsulated nucleic acid drug: A combined study of dynamic PET imaging and LC/MS/MS analysis
Hidefumi Mukai et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Improved Immuno-PET Imaging of HER2-Positive Tumors in Mice: Urokinase Injection-Triggered Clearance Enhancement of 64Cu-Trastuzumab
Qui Ren et al.
MOLECULAR PHARMACEUTICS (2019)
Development of [18F]FPy-WL12 as a PD-L1 Specific PET Imaging Peptide
Wojciech G. Lesniak et al.
MOLECULAR IMAGING (2019)
Imaging fibrosis in inflammatory diseases: targeting the exposed extracellular matrix
Nicolas Beziere et al.
THERANOSTICS (2019)
Site-Selective Cysteine-Cyclooctyne Conjugation
Chi Zhang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
64Cu-Labeled Phosphonate Cross-Bridged Chelator Conjugates of c(RGDyK) for PET/CT Imaging of Osteolytic Bone Metastases
Meltem Ocak et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2018)
Urokinase injection-triggered clearance enhancement of a 4-arm PEG-conjugated 64Cu-bombesin analog tetramer: A novel approach for the improvement of PET imaging contrast
Kazushi Matsumura et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Peptide-Based 68Ga-PET Radiotracer for Imaging PD-L1 Expression in Cancer
Ravindra A. De Silva et al.
MOLECULAR PHARMACEUTICS (2018)
89Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection
Eric W. Price et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Hepatocyte growth factor/MET in cancer progression and biomarker discovery
Kunio Matsumoto et al.
CANCER SCIENCE (2017)
Non-Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases
Hideko Isozaki et al.
CANCER RESEARCH (2016)
Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3
Haojun Chen et al.
THERANOSTICS (2016)
Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
Garrett M. Frampton et al.
CANCER DISCOVERY (2015)
New cross-bridged cyclam derivative CB-TE1K1P, an improved bifunctional chelator for copper radionuclides
Dexing Zeng et al.
CHEMICAL COMMUNICATIONS (2014)
64Cu-Labeled Somatostatin Analogues Conjugated with Cross-Bridged Phosphonate-Based Chelators via Strain-Promoted Click Chemistry for PET Imaging: In silico through in Vivo Studies
Zhengxin Cai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
Makiko Kawaguchi et al.
CANCERS (2014)
Binding of transition metal ions to albumin: Sites, affinities and rates
Wojciech Bal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Renal Uptake of 99mTc-Dimercaptosuccinic Acid Is Dependent on Normal Proximal Tubule Receptor-Mediated Endocytosis
Kathrin Weyer et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Preparation and Biological Evaluation of 64Cu Labeled Tyr3-Octreotate Using a Phosphonic Acid-Based Cross-Bridged Macrocyclic Chelator
Yunjun Guo et al.
BIOCONJUGATE CHEMISTRY (2012)
Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy
Maria J. W. D. Vosjan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma
Qian Xie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Dynamic PET and Optical Imaging and Compartment Modeling using a Dual-labeled Cyclic RGD Peptide Probe
Lei Zhu et al.
THERANOSTICS (2012)
A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma
Patrick Schoffski et al.
BJU INTERNATIONAL (2011)
Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors
Jie Qi et al.
CANCER RESEARCH (2011)
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
Erik Vegt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Development of Ga-68-Glycopeptide as an Imaging Probe for Tumor Angiogenesis
Ning Tsao et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Fityk: a general-purpose peak fitting program
Marcin Wojdyr
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2010)
Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
Erik Vegt et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
PET Imaging of Leptin Biodistribution and Metabolism in Rodents and Primates
Giovanni Ceccarini et al.
CELL METABOLISM (2009)
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
Seiji Yano et al.
CANCER RESEARCH (2008)
Interactions of hepatocyte growth factor/scatter factor with various glycosaminoglycans reveal an important interplay between the presence of iduronate and sulfate density
Krista R. Catlow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Peptide transporters: Structure, function, regulation and application for drug delivery
T Terada et al.
CURRENT DRUG METABOLISM (2004)
Share Paper
